Compare DOV & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOV | VEEV |
|---|---|---|
| Founded | 1947 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5B | 28.9B |
| IPO Year | 1994 | 2013 |
| Metric | DOV | VEEV |
|---|---|---|
| Price | $203.85 | $178.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 26 |
| Target Price | $223.20 | ★ $283.80 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 04-30-2026 | 05-29-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ 34.16 |
| EPS | ★ 7.94 | 3.96 |
| Revenue | ★ $6,992,118,000.00 | $1,104,081,000.00 |
| Revenue This Year | $6.95 | $13.64 |
| Revenue Next Year | $4.40 | $12.67 |
| P/E Ratio | ★ $25.64 | $45.77 |
| Revenue Growth | 2.51 | ★ 28.05 |
| 52 Week Low | $143.04 | $168.14 |
| 52 Week High | $237.54 | $310.50 |
| Indicator | DOV | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 38.52 |
| Support Level | $197.41 | $169.92 |
| Resistance Level | $210.75 | $184.71 |
| Average True Range (ATR) | 5.03 | 7.38 |
| MACD | -3.16 | 1.11 |
| Stochastic Oscillator | 6.72 | 19.86 |
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.